Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)

Memorial Sloan Kettering Cancer Center · 2025
ClinicalTrials.gov · Datasets · License: Public Domain · 2025
Open Source ↗
primary central nervous system lymphoma (pcnsl), primary central nervous system lymphoma, relapsed primary central nervous system lymphoma, refractory primary central nervous system lymphoma, central nervous system lymphoma, secondary central nervous system lymphoma, secondary central nervous system lymphoma (scnsl), pcnsl, relapsed primary central nervous lymphoma, refractory primary central nervous lymphoma, scnsl, epcoritamab
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 804998
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.